• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

SMG 1410.202

FDA STAFF MANUAL GUIDES, VOLUME II - DELEGATIONS OF AUTHORITY

REGULATORY - BIOLOGICS

REDELEGATION OF THE CENTER FOR BIOLOGICS EVALUATION AND RESEARCH DIRECTOR'S PROGRAM AUTHORITIES

Effective Date: 06/27/2003

[PDF Version]

1. AUTHORITY DELEGATED AND TO WHOM DELEGATED.

The following officials are authorized to perform all the functions of the Director, Center for Biologics Evaluation and Research (CBER) with regard to program authorities for their respective areas:

1. Deputy Directors, CBER.

2. Associate Directors, CBER.

3. Office Directors, CBER.

4. Division Directors, CBER.

5. Director and Deputy Director, CDER.

6. Director and Deputy Director, Office of New Drugs, CDER.

7. Director and Deputy Director, Office of Pharmaceutical Science, CDER.

2. REDELEGATION.

These officials may not further redelegate these authorities.

3. EFFECTIVE DATE.

This delegation was signed by the Commissioner on June 27, 2003.